Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases May 29, 2020
Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call April 6, 2020
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies April 2, 2020
Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com March 10, 2020
Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen February 11, 2020
Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine December 23, 2019
